trial · primary record
Verteporfin
Glioblastoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 9 |
| Primary completion | 2025-02-13 |
| Primary endpoint | Incidence of Adverse Events (Phase I) |
| Registry ID | NCT04590664 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:05.085Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04590664
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.